CCL5 and neoplasm: Although the exact molecular mechanism has not yet been clarified, it was found that PTH-AS expression in T47D cells upregulates STAT1 and its downstream cancer-promoting IRDS and CCL5, resulting in enhanced tumor malignancies (Fig. S25).